Human trial: Popular diabetes drug shown to lower inflammation, which may protect the heart
October 05, 2026
October 05, 2026
NASHVILLE, Tennessee, Oct. 5 -- Vanderbilt University Medical Center posted the following news release:
* * *
Human trial: Popular diabetes drug shown to lower inflammation, which may protect the heart
*
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose-lowering benefits, has been shown to also reduce inflammatory cells in the blood k . . .
* * *
Human trial: Popular diabetes drug shown to lower inflammation, which may protect the heart
*
For the first time in a human trial, a class of drugs known as sodium-glucose cotransporter-2 (SGLT2) inhibitors, already known for their weight loss and glucose-lowering benefits, has been shown to also reduce inflammatory cells in the blood k . . .